November 13, 2022 from 6:30 pm – 8:30 pm EST
Join expert faculty as they discuss the importance of the multidisciplinary team discussion in the process of identifying and managing patients with autoimmune-associated interstitial lung diseases. Rheumatologist Ara Dikranian, MD, and radiologist Joseph Mammarappallil, MD, will utilize de-identified patient cases to present common clinical and radiographic features seen in this patient group and the multidisciplinary approach to manage their disease. Faculty will also discuss the updated guideline on progressive pulmonary fibrosis.
This program is developed and offered by Boehringer Ingelheim Pharmaceuticals, Inc. This is not an official program of the American College of Rheumatology.
This is a non-CME event and does not qualify for CME or CE credit. Onsite registration/admission will occur for conference registrants on a first-come, first-serve basis.
Presentation content has been reviewed for consistency with FDA guidelines and is not approved for continuing education credit. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.
Ara Dikranian, MD
Cabrillo Center for Rheumatic Disease
San Diego, California
Joseph G. Mammarappallil, MD, PhD
Duke University Medical Center
Department of Radiology
Assistant Professor, Cardiothoracic Division
This is not an official program of the American College of Rheumatology.